<- Go Home
Compex Technologies, Inc.
As of November 11, 2005, Compex Technologies Inc. was acquired by DJO Global Inc. Compex Technologies, Inc. engages in the design and manufacture of electrical stimulation products for pain management, rehabilitation, fitness, and sports performance enhancement primarily in the United States and Europe. These products are used in clinical, home healthcare, sports, and occupational medicine settings. The company manufactures, sells, and rents electrical stimulation products that use different modalities to deliver electrical current through electrodes placed on the skin for pain management, rehabilitation, and edema reduction as medical devices; and for sports performance enhancement and muscle toning as consumer products. Its product portfolio includes transcutaneous electrical nerve stimulation, interferential stimulation, neuromuscular electrical stimulation, pulsed direct current stimulation, traction, and iontophoresis devices. The company’s consumer product line is sold over-the-counter and is designed for sports performance enhancement, fitness, and health and wellness. It also distributes complementary medical devices and consumer products manufactured by others under other name brands. The company also sells medical device accessories and supplies, including self-adhesive, reusable, and disposable electrodes; lead wires; batteries; and AC power packs. Compex Technologies markets its consumer products through independent sales representatives to sporting goods stores, specialty shops, pharmacies, and chain stores in Europe. Compex Technologies, Inc. was formerly known as Rehabilicare, Inc. The company was incorporated in 1972 and is based in New Brighton, Minnesota with an additional office in Switzerland.
Market Cap
$106.4M
Volume
50.6K
Cash and Equivalents
$4.0M
EBITDA
$9.9M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$71.5M
Profit Margin
67.24%
52 Week High
$8.41
52 Week Low
$3.06
Dividend
N/A
Price / Book Value
1.71
Price / Earnings
27.86
Price / Tangible Book Value
2.40
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$8.0M
Return on Equity
6.43%
Return on Assets
5.53
Cash and Short Term Investments
$4.0M
Debt
$19.6M
Equity
$61.9M
Revenue
$106.4M
Unlevered FCF
-$5.9M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium